BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2026 3:52:12 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-08 06:41 |
 |
Peer-Review Started |
|
2026-01-08 06:41 |
 |
First Decision by Editorial Office Director |
|
2026-01-16 06:48 |
 |
Return for Revision |
|
2026-01-16 06:48 |
 |
Revised |
|
2026-01-16 18:38 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-06 02:48 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-06 12:06 |
 |
Articles in Press |
|
2026-02-06 12:06 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-05-14 04:57 |
 |
Publish the Manuscript Online |
|
2026-05-26 03:52 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Opinion Review |
| Article Title |
RSV in Cirrhosis: Time to Separate Data from Dogma?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jorge Quarleri and María Victoria Delpino |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jorge Quarleri, PhD, Principal Investigator, Professor, Senior Researcher, Tenured Professor, Instituto de Investigaciones Biomédicas en Retrovirus y Sida, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Paraguay 2155, Buenos Aires C1121ABG, Argentina. quarleri@fmed.uba.ar |
| Key Words |
Respiratory syncytial virus; Cirrhosis; Vaccine; Influenza virus; SARS-CoV-2; COVID-19 |
| Core Tip |
Although cirrhosis is frequently categorized as a high-risk condition for adult RSV infection, direct evidence supporting this classification remains limited. Recent real-world data indicate that RSV-related hospitalizations among patients with cirrhosis are uncommon and not independently associated with increased mortality, in contrast to the well-established risk observed in cardiopulmonary and renal diseases. Consequently, current RSV vaccination recommendations for individuals with cirrhosis rely largely on extrapolation rather than robust cirrhosis-specific evidence. Until stronger data become available, RSV vaccination in cirrhosis should be individualized, taking into account age and co-morbidities, while prioritizing multicenter studies to better define true risk and clinical benefit. |
| Publish Date |
2026-05-26 03:52 |
| Citation |
Quarleri J, Delpino MV. RSV in Cirrhosis: Time to Separate Data from Dogma? World J Hepatol 2026; 18(5): 118665 |
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i5/118665.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v18.i5.118665 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.